This company develops an AI-powered platform for bioproduction, integrating a genome-to-factory model with a precision biofoundry. They utilize automated wet-lab processes and proprietary data collection to accelerate strain development for industrial ingredients. The platform supports standardized bioprocesses to ensure efficient scaling and high-quality product output.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Industrial synthesis of high‑value molecules often relies on petrochemical routes or low‑throughput microbial screening, leading to high carbon footprints, long development cycles, and unpredictable yields. Scaling a promising strain from lab to production requires extensive trial‑and‑error and costly data collection, limiting the ability to meet market demand for sustainable ingredients.
Solution
baCta delivers an end‑to‑end bioproduction platform that couples a genome‑to‑factory artificial‑intelligence model with a precision biofoundry. The AI engine integrates multi‑omics datasets and metabolic pathway simulations to predict optimal genetic designs, reducing the number of experimental iterations. Automated wet‑lab robotics execute the designed builds, while standardized fermentation and downstream purification modules translate the best candidates into scalable industrial processes. All data are captured in a proprietary repository and processed through cloud‑based analytics, providing real‑time performance metrics and rapid iteration loops. The platform currently demonstrates the approach with microbial production of astaxanthin and is extensible to other high‑value industrial ingredients.
Target Audience
Primary customers are industrial biotechnology firms, chemical manufacturers, and contract manufacturing organizations that require rapid, cost‑effective development of microbial strains for high‑value ingredients such as nutraceuticals, pigments, and specialty chemicals.
Features
- Genome‑to‑factory AI model that combines genome‑scale metabolic modeling, machine‑learning‑driven design space exploration, and predictive phenotype forecasting
- High‑throughput robotic biofoundry equipped with automated strain construction, liquid handling, and real‑time analytics for rapid build‑test cycles
- Proprietary data acquisition pipeline that logs multi‑omics, process, and quality attributes into a centralized knowledge base
- Modular fermentation system with scalable bioreactor control, inline monitoring, and adaptive feeding strategies to maintain optimal productivity
- Integrated downstream purification suite (cell‑lysis, chromatography, crystallization) optimized for product quality and cost efficiency
- Cloud‑hosted analytics dashboard offering KPI tracking, batch‑level traceability, and automated design‑of‑experiments recommendations
- API layer for seamless integration with enterprise Manufacturing Execution Systems (MES) and Enterprise Resource Planning (ERP) platforms
- Standardized bioprocess templates that accelerate regulatory documentation and technology transfer to contract manufacturing organizations (CMOs)